首頁 > 市場調查報告書 > 醫療設備

導管

市場調查報告書

商品編碼

1457993

全球髂動脈支架市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Iliac Stent Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年03月01日 | 出版商:

Value Market Research | 英文 175 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球髂動脈支架市場需求預計將從2023年的16億美元達到2032年近27.7億美元的市場規模，2024-2032年研究期間CAGR為6.29%。

髂動脈支架是一種插入髂動脈的小型網狀管，用於治療週邊動脈疾病 (PAD) 等疾病。這些支架透過為動脈提供結構支撐、防止阻塞和改善骨盆區域的循環來幫助恢復血流。放置這種支架是一種常見的醫療干預措施，用於緩解與血流減少相關的腿部疼痛和痙攣等症狀。

市場動態

髂動脈支架市場主要是由周邊動脈疾病（PAD）盛行率不斷上升所推動的，特別是在老年人口中，通常用於治療髂動脈狹窄或阻塞。此外，支架設計、材料和輸送系統的持續技術進步有助於提高療效和安全性，吸引醫療保健提供者和患者。鑑於老年人血管疾病的發生率較高，全球人口老化也增加了對髂支架的需求。此外，與傳統的開放性手術選擇相比，由於恢復時間縮短和發病率較低，人們對微創手術（例如髂動脈支架置入術等血管內介入治療）的偏好正在上升。最後，對周圍血管疾病的認知提高和診斷技術的進步有助於早期發現和治療，進一步推動市場。然而，與髂支架手術和設備相關的高成本可能會阻礙市場成長。這種經濟障礙可能會限制採用，特別是在財政拮据或醫療基礎設施不足的地區，從而影響市場的成長潛力。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具也對全球髂支架市場的各個細分市場進行了包容性評估。髂支架產業的成長和趨勢為本研究提供了整體方法。

市場區隔

髂支架市場報告的這一部分提供了國家和區域層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按類型

自擴張支架
球囊擴張支架
其他

依動脈病變分類

髂總動脈病變
嚴重鈣化病變
完全性阻塞性病變

按最終用途

醫院
門診設施
其他

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲地區髂動脈支架市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

全球髂動脈支架市場佔有率（按地區）（代表性圖）
全球髂動脈支架市場佔有率

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。髂動脈支架市場的主要參與者包括 BD、雅培、波士頓科學公司、WL Gore & Associates, Inc.、庫克、美敦力、iVascular、Terumo Corporation、Biotronik SE & Co KG、Getinge AB。本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來產能、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區國家/地區銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 9 章：髂動脈支架公司的競爭格局

髂動脈支架市場競爭
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 10 章：公司簡介

公司股份分析
市場集中度
BD

公司簡介
公司收入
產品
最近的發展

Abbott

公司簡介
公司收入
產品
最近的發展

Boston Scientific Corporation

公司簡介
公司收入
產品
最近的發展

WL Gore & Associates Inc.

公司簡介
公司收入
產品
最近的發展

Cook

公司簡介
公司收入
產品
最近的發展

Medtronic

公司簡介
公司收入
產品
最近的發展

iVascular

公司簡介
公司收入
產品
最近的發展

Terumo Corporation

公司簡介
公司收入
產品
最近的發展

Biotronik SE & Co KG

公司簡介
公司收入
產品
最近的發展

Getinge AB.

公司簡介
公司收入
產品
最近的發展

注意 - 在公司概況中，財務詳細資訊和近期發展視情況而定，或者如果是私人公司，則可能不包括在內

簡介目錄圖表

Product Code: VMR112113948

The global demand for Iliac Stent Market is presumed to reach the market size of nearly USD 2.77 Billion by 2032 from USD 1.6 Billion in 2023 with a CAGR of 6.29% under the study period 2024 - 2032.

An Iliac stent is a small, mesh-like tube inserted into the iliac arteries to treat conditions like peripheral artery disease (PAD). These stents help restore blood flow by providing structural support to the arteries, preventing blockages, and improving circulation in the pelvic region. Placement of this stent is a common medical intervention to alleviate symptoms such as leg pain and cramping associated with reduced blood flow.

MARKET DYNAMIC

The Iliac stent market is primarily driven by the escalating prevalence of peripheral artery disease (PAD), particularly among the aging population, commonly used to treat iliac artery stenosis or occlusion. Furthermore, ongoing technological advancements in stent design, materials, and delivery systems contribute to improved efficacy and safety, attracting healthcare providers and patients. The growing aging demographic globally also enhances the demand for Iliac stents, given the higher incidence of vascular diseases in older individuals. Furthermore, the preference for minimally invasive procedures, such as endovascular interventions like Iliac stenting, is on the rise due to reduced recovery times and lower morbidity rates compared to traditional open surgical options. Lastly, improved awareness of peripheral vascular diseases and advancements in diagnostic techniques contribute to early detection and treatment, further driving the market. However, the high cost associated with Iliac stent procedures and devices may hamper the market growth. This economic barrier may limit adoption, particularly in regions with financial constraints or inadequate healthcare infrastructure, thus impacting the market's growth potential.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of iliac stent. The growth and trends of iliac stent industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the iliac stent market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Self-Expandable Stents
Balloon-Expandable Stents
Others

By Artery Lesions

Common Iliac Artery Lesions
Severe Calcified Lesions
Complete Obstructive Lesions

By End-Use

Hospitals
Outpatient Facilities
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Iliac Stent market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

GLOBAL ILIAC STENT MARKET SHARE BY REGION (REPRESENTATIVE GRAPH)
Global Iliac Stent Market Share

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Iliac Stent market include BD, Abbott, Boston Scientific Corporation, W. L. Gore & Associates, Inc., Cook, Medtronic, iVascular, Terumo Corporation, Biotronik SE & Co KG, Getinge AB. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE

1.1. Report Description
- 1.1.1. Objective
- 1.1.2. Target Audience
- 1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1. Market Research Process
- 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3 . ILIAC STENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Artery Lesions
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1. List of Raw Materials
- 4.2.2. Raw Material Manufactures List
- 4.2.3. Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1. Direct Marketing
- 4.4.2. Indirect Marketing
- 4.4.3. Marketing Channel Development Trend

5 . GLOBAL ILIAC STENT MARKET ANALYSIS BY TYPE

5.1 Overview by Type
5.2 Historical and Forecast Data
5.3 Analysis by Type
5.4 Self-Expandable Stents Historic and Forecast Sales by Regions
5.5 Balloon-Expandable Stents Historic and Forecast Sales by Regions
5.6 Others Historic and Forecast Sales by Regions

6 . GLOBAL ILIAC STENT MARKET ANALYSIS BY ARTERY LESIONS

6.1 Overview by Artery Lesions
6.2 Historical and Forecast Data
6.3 Analysis by Artery Lesions
6.4 Common Iliac Artery Lesions Historic and Forecast Sales by Regions
6.5 Severe Calcified Lesions Historic and Forecast Sales by Regions
6.6 Complete Obstructive Lesions Historic and Forecast Sales by Regions

7 . GLOBAL ILIAC STENT MARKET ANALYSIS BY END-USE

7.1 Overview by End-Use
7.2 Historical and Forecast Data
7.3 Analysis by End-Use
7.4 Hospitals Historic and Forecast Sales by Regions
7.5 Outpatient Facilities Historic and Forecast Sales by Regions
7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL ILIAC STENT MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1. Overview, Historic and Forecast Data Sales Analysis
- 8.3.2. North America By Segment Sales Analysis
- 8.3.3. North America By Country Sales Analysis
- 8.3.4. United State Sales Analysis
- 8.3.5. Canada Sales Analysis
- 8.3.6. Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1. Overview, Historic and Forecast Data Sales Analysis
- 8.4.2. Europe by Segment Sales Analysis
- 8.4.3. Europe by Country Sales Analysis
- 8.4.4. United Kingdom Sales Analysis
- 8.4.5. France Sales Analysis
- 8.4.6. Germany Sales Analysis
- 8.4.7. Italy Sales Analysis
- 8.4.8. Russia Sales Analysis
- 8.4.9. Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1. Overview, Historic and Forecast Data Sales Analysis
- 8.5.2. Asia Pacific by Segment Sales Analysis
- 8.5.3. Asia Pacific by Country Sales Analysis
- 8.5.4. China Sales Analysis
- 8.5.5. India Sales Analysis
- 8.5.6. Japan Sales Analysis
- 8.5.7. South Korea Sales Analysis
- 8.5.8. Australia Sales Analysis
- 8.5.9. South East Asia Sales Analysis
- 8.5.10. Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1. Overview, Historic and Forecast Data Sales Analysis
- 8.6.2. Latin America by Segment Sales Analysis
- 8.6.3. Latin America by Country Sales Analysis
- 8.6.4. Brazil Sales Analysis
- 8.6.5. Argentina Sales Analysis
- 8.6.6. Peru Sales Analysis
- 8.6.7. Chile Sales Analysis
- 8.6.8. Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1. Overview, Historic and Forecast Data Sales Analysis
- 8.7.2. Middle East & Africa by Segment Sales Analysis
- 8.7.3. Middle East & Africa by Country Sales Analysis
- 8.7.4. Saudi Arabia Sales Analysis
- 8.7.5. UAE Sales Analysis
- 8.7.6. Israel Sales Analysis
- 8.7.7. South Africa Sales Analysis
- 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE ILIAC STENT COMPANIES

9.1. Iliac Stent Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10 . COMPANY PROFILES OF ILIAC STENT INDUSTRY

10.1. Company Share Analysis
10.2. Market Concentration Rate
10.3. BD
- 10.3.1. Company Overview
- 10.3.2. Company Revenue
- 10.3.3. Products
- 10.3.4. Recent Developments
10.4. Abbott
- 10.4.1. Company Overview
- 10.4.2. Company Revenue
- 10.4.3. Products
- 10.4.4. Recent Developments
10.5. Boston Scientific Corporation
- 10.5.1. Company Overview
- 10.5.2. Company Revenue
- 10.5.3. Products
- 10.5.4. Recent Developments
10.6. W. L. Gore & Associates Inc.
- 10.6.1. Company Overview
- 10.6.2. Company Revenue
- 10.6.3. Products
- 10.6.4. Recent Developments
10.7. Cook
- 10.7.1. Company Overview
- 10.7.2. Company Revenue
- 10.7.3. Products
- 10.7.4. Recent Developments
10.8. Medtronic
- 10.8.1. Company Overview
- 10.8.2. Company Revenue
- 10.8.3. Products
- 10.8.4. Recent Developments
10.9. iVascular
- 10.9.1. Company Overview
- 10.9.2. Company Revenue
- 10.9.3. Products
- 10.9.4. Recent Developments
10.10. Terumo Corporation
- 10.10.1. Company Overview
- 10.10.2. Company Revenue
- 10.10.3. Products
- 10.10.4. Recent Developments
10.11. Biotronik SE & Co KG
- 10.11.1. Company Overview
- 10.11.2. Company Revenue
- 10.11.3. Products
- 10.11.4. Recent Developments
10.12. Getinge AB.
- 10.12.1. Company Overview
- 10.12.2. Company Revenue
- 10.12.3. Products
- 10.12.4. Recent Developments